A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer

被引：0

作者：

Masahiro Tabata

Katsuyuki Kiura

Niro Okimoto

Yoshihiko Segawa

Tetsu Shinkai

Toshiro Yonei

Shoichi Kuyama

Shingo Harita

Katsuyuki Hotta

Hiroshi Ueoka

Mitsune Tanimoto

机构：

[1] Okayama University Medical School,Department of Medicine II

[2] Kawasaki Hospital,Department of Medicine

[3] National Hospital Organization Shikoku Cancer Center,Department of Medicine

[4] National Hospital Organization Okayama Medical Center,Department of Respiratory Medicine

[5] Chugoku Central Hospital,Department of Medicine

[6] National Hospital Organization National Sanyo Hospital,Department of Medicine

来源：

Cancer Chemotherapy and Pharmacology | 2007年 / 60卷

关键词：

Small-cell lung cancer; Alternating chemotherapy; Irinotecan;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1 / 6

页数：5

共 50 条

[21] Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
Young Saing Kim
Se Hoon Park
Sun Young Kyung
Sun Jin Sym
Sang Pyo Lee
Jeong Woong Park
Sung Hwan Jung
Jinny Park
Eun Kyung Cho
Jae Hoon Lee
Dong Bok Shin
Medical Oncology, 2011, 28 : 342 - 350
[22] Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer
Lara, Primo N., Jr.
Gandara, David R.
Natale, Ronald B.
CLINICAL LUNG CANCER, 2006, 7 (05) : 353 - 356
[23] Modified one-day etoposide and cisplatin combination for previously untreated extensive-disease small-cell lung cancer: A retrospective evaluation of 36 cases
Cho, Su-Hee
Kim, Hyun Kuk
Jang, Hang Jea
Park, Min Jae
MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 914 - 918
[24] Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer
Kim, Hoon-Gu
Lee, Gyeong-Won
Kang, Jung Hun
Kang, Myung-Hee
Hwang, In-Gyu
Kim, Seok Hyun
Hahm, Jong Ryeal
Jeong, Yi Yeong
Kim, Ho-Cheol
Lee, Jong Duk
Lee, Jong-Seok
Hwang, Young Sil
LUNG CANCER, 2008, 61 (02) : 220 - 226
[25] Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer
Lee, G.
Kim, K.
Cho, Y.
Kim, H.
Hwang, I.
Kim, H.
Kang, J.
Jang, J.
Lee, J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[26] Paclitaxel/epirubicin/etoposide in patients with extensive-disease small-cell lung cancer (SCLC)
Baldini, E
Chella, A
Del Freo, A
Gragnani, F
Angeletti, CA
Conte, PF
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S257 - S258
[27] ETOPOSIDE, CARBOPLATIN, CYCLOPHOSPHAMIDE AND VINCRISTINE IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER
BISHOP, JF
KEFFORD, R
RAGHAVAN, D
ZALCBERG, J
STUARTHARRIS, R
BALL, D
OLVER, IN
FRIEDLANDER, M
BULL, C
YUEN, K
MATTHEWS, JP
ZIMET, A
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (05) : 367 - 370
[28] A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer
Ji-Youn Han
Dae Ho Lee
Sung Young Lee
Chun Gun Park
Hae Young Kim
Eun-A Kim
Sung Min Yoon
Hong Gi Lee
Jin Soo Lee
Medical Oncology, 2005, 22 : 281 - 290
[29] A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer
Han, JY
Lee, DH
Lee, SY
Park, CG
Kim, HY
Kim, EA
Yoon, SM
Lee, HG
Lee, JS
MEDICAL ONCOLOGY, 2005, 22 (03) : 281 - 290
[30] Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
Noda, W
Nishiwaki, Y
Kawahara, M
Negoro, S
Sugiura, T
Yokoyama, A
Fukuoka, M
Mori, K
Watanabe, K
Tamura, T
Yamamoto, S
Saijo, N
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02): : 85 - 91

← 1 2 3 4 5 →